ArticlePloS one2013

RKIP inhibition in cervical cancer is associated with higher tumor aggressive behavior and resistance to cisplatin therapy.

Olga Martinho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.